Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases Download the PDF here. This post appeared first on investingnews.com Related Posts Extension of Broker Option and Retail Offer February 22, 2025 IperionX Announces US$47.1 Million Titanium Deal with US Department of Defense February 22, 2025 i-80 Gold Releases PEAs for Cove and Archimedes Projects in Nevada February 22, 2025